At Peptomyc we believe in forging strategic partnerships that will ultimately enable us to drive Myc inhibition into the clinic as an effective anti-cancer therapy across multiple tumor types. We therefore welcome your interest, questions or any queries you may have surrounding Peptomyc. Please do contact us directly:
Chief-Executive-Officer: Laura Soucek
Email: lsoucek@peptomyc.com
Chief-Scientific-Officer: Marie-Eve Beaulieu
Email: mbeaulieu@peptomyc.com